New Home

[rev_slider alias=”new-activities” /]

Consorzio per Valutazioni Biologiche e Farmacologiche (CVBF) is a non-profit scientific organisation, founded in 2000 with the mission to perform research and education in the life sciences, biotechnologies, and pharmaceutical fields. Its main focus is drug development for small populations (paediatric and rare diseases).

Consorzio per Valutazioni Biologiche e Farmacologiche (CVBF) mission is to enhance technology-driven paediatric research in drug discovery and early development phases to be translated into clinical research. CVBF promotes networking within the scientific community and collaboration between stakeholders to harness efficiency of the European research infrastructures and delivery of research services. CVBF supports adequate policies pushing towards higher scientific, ethical and societal standards for a better implementation of health systems and allocation of resources. CVBF activities are organised within two operational areas Development&Networking and Clinical Research.

Latest News

SAVE THE DATE: “Pharmacovigilance: common assessment tools and Promoter responsibility – 25 June 2019, Rome

maria2019-05-31T11:12:03+00:00May 3rd, 2019|0 Comments

On 25 June 2019, a workshop entitled “ Pharmacovigilance: common assessment tools and Promoter responsibility” will be held at University Polyclinic “Agostino Gemelli” in Rome. Dr. Mariagrazia Felisi, Clinical Research Director at Consorzio per Valutazioni [...]

CVBF Launches the ClinicalResearch.Education Platform and its GCP R3 Course

CVBF is proud to announce the launch of ClinicalResearch.Education, a new dedicated e-learning platform developed to deliver high-quality, accessible training to clinical research professionals across Europe and beyond. As its inaugural offering, the platform presents the [...]

Celebrating 25 Years of Excellence: CVBF Achieves New Standards of Trust with ISO 9001 and ISO 27001 Certifications

We're thrilled to announce that CVBF has successfully obtained both ISO 9001 and ISO 27001 certifications-a powerful dual achievement that reinforces our position as a quality-driven, security-focused partner in European clinical research. As we celebrate 25 [...]